Analyst Ratings for BioCryst Pharma (BCRX)
BCRX Rating Summary
BCRX Price Target Summary
- Highest: $14.00 (JMP Securities)
- Lowest: $6.00 (Barclays)
- Average: $10.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.14 (+100.1%)
* Over Last 12-Mos
Rating Score: 8.1 / 10 Percentile Rank: 85%
Rating Score: 8.1 / 10 Percentile Rank: 85%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/20/2023 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
10.00 (N/A) |
5.14 (5.07) |
-1.36% | Details |
9/18/2023 | RBC Capital | Brian Abraham | Upgrade | Outperform (Sector Perform) |
10.00 (9.00) |
6.85 (5.07) |
-25.99% | Details |